Related Experiment Video
Updated: Dec 30, 2025

16:49
Multifocal Electroretinograms
Published on: December 4, 2011
18.8K
Multifocal intraocular lenses and retinal diseases
Andrzej Grzybowski1,2, Piotr Kanclerz3, Raimo Tuuminen4,5
1Department of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland. ae.grzybowski@gmail.com.
Summary
Multifocal intraocular lenses (MIOLs) may be suitable for patients with retinal diseases, as they do not significantly impair contrast sensitivity (CS). Some studies even show improved visual outcomes and patient satisfaction with MIOLs in these populations.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Intraocular Lens Technology
Background:
- Multifocal intraocular lenses (MIOLs) are typically contraindicated in patients with retinal disorders due to concerns about reduced contrast sensitivity (CS).
- Existing concerns also involve visual field defects, fixation instability, or eccentric preferred retinal locations.
- The impact of MIOLs on visual quality in patients with retinal conditions requires thorough investigation.
Purpose of the Study:
- To review the influence of MIOLs on the quality of vision in patients diagnosed with retinal diseases.
- To synthesize current evidence regarding MIOL performance in the context of retinal pathologies.
Main Methods:
- A systematic literature search was conducted using PubMed and Web of Science databases.
- Keywords included: multifocal intraocular lens, cataract surgery, diabetic retinopathy, age-related macular degeneration, and contrast sensitivity.
- Relevant studies evaluating visual outcomes and CS were identified and analyzed.
Main Results:
- Studies on CS with MIOLs show mixed results, with some indicating no significant difference and others reporting decreased performance under specific low-light or high-frequency conditions compared to monofocal IOLs.
- Despite variations, MIOLs generally maintained CS within the normal age-matched range.
- Two studies reported significant improvements in visual-related outcomes for patients with retinal diseases receiving MIOLs, with some preferring a mix of monofocal and multifocal IOLs for enhanced subjective satisfaction.
Conclusions:
- Current evidence does not support advising against MIOLs for patients with retinal diseases.
- Further research is necessary to fully understand and optimize MIOL use in eyes affected by retinal conditions.
- Addressing specific concerns related to contrast sensitivity and visual field integrity remains a priority for future studies.
Related Concept Videos
Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
Focusing of Light in the Eye
5.1K
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
5.1K
Photoreceptors and Visual Pathways
8.5K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.5K
Open Angle Glaucoma: Treatment
905
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
905
Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K

